| Certification: | ISO, Kosher |
|---|---|
| Assay Method: | HPLC |
| Application: | Food, Health Care Products |
| State: | Powder |
| Extract Source: | Ginkgo Biloba |
| Color: | Light Brown |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier Product Name: Ginkgo biloba extract
Latin Name: Ginkgo biloba L.
Specification: 24% Ginkgo-flavone glycosides & 6% terpenone lactones
24% Ginkgo-flavone glycosides
USP grade, EP grade.
Test Method:HPLC
Part of used: Leaf
Appearance: Light Brown powder
TECHNICAL DATE SHEET
| TECHNICAL DATE SHEET | ||
| PRODUCT SPECIFICATIONS | ||
| Product Name: | Ginkgo biloba extract | |
| Botanic Name: | Ginkgo biloba L. | |
| Part of plant | Leaf | |
| Solvent extraction | Waterðanol | |
| Country of Origin: | China | |
| Excipent | None | |
| ANALYSIS ITEMS | SPECIFICATION | TEST METHOD |
| Appearance | Fine powder | Organoleptic |
| Color | Light Brown powder | |
| Odour & Taste | Characteristic | Organoleptic |
| Identification | Identical to R.S. sample | HPTLC |
| Ginkgo-flavone glycosides | NLT 24.0% | HPLC |
| Sieve Analysis | 100% through 80 mesh | USP39 <786> |
| Loss on drying | ≤ 5.0% | Eur.Ph.9.0 [2.5.12] |
| Total Ash | ≤ 5.0% | Eur.Ph.9.0 [2.4.16] |
| Lead (Pb) | ≤ 3.0 mg/kg | Eur.Ph.9.0<2.2.58>ICP-MS |
| Arsenic (As) | ≤ 1.0 mg/kg | Eur.Ph.9.0<2.2.58>ICP-MS |
| Cadmium(Cd) | ≤ 1.0 mg/kg | Eur.Ph.9.0<2.2.58>ICP-MS |
| Mercury(Hg) | ≤ 0.1 mg/kg -Reg.EC629/2008 | Eur.Ph.9.0<2.2.58>ICP-MS |
| Heavy metal | ≤ 10.0 mg/kg | Eur.Ph.9.0<2.4.8> |
| Solvents Residue | Conform Eur.ph. 9.0 <5,4 > and EC European Directive 2009/32 | Eur.Ph.9.0<2.4.24> |
| Pesticides Residues | Conform Regulations(EC) No.396/2005 including annexes and successive updates Reg.2008/839/CE | Gas Chromatography |
| Aerobic bacteria(TAMC) | ≤1000 cfu/g | USP39 <61> |
| Yeast/Moulds(TAMC) | ≤100 cfu/g | USP39 <61> |
| Escherichia coli: | Absent in 1g | USP39 <62> |
| Salmonella spp: | Absent in 25g | USP39 <62> |
| Staphylococcus aureus: | Absent in 1g | |
| Listeria Monocytogenens | Absent in 25g | |
| Aflatoxins B1 | ≤ 5 ppb -Reg.EC 1881/2006 | USP39 <62> |
| Aflatoxins ∑ B1, B2, G1, G2 | ≤ 10 ppb -Reg.EC 1881/2006 | USP39 <62> |
| Packing | Pack in paper-drums and two plastic-bags inside N.W. 25 kgs I.D.35xH51cm. | |
| Storage | Store in a well-closed container away from moisture, light, oxygen. | |
| Shelf Life | 24 months under the conditions above and in its original packaging | |
1. Ginkgo Biloba Extract for the analgesic effect and fever:
Resveratrol, through a variety of different ways to play therapy efficacy, the display have antipyretic and analgesic activity, as in mice and rats complete institute (Lin and hu, 1987). It extracts show shall be given in case does not affect blood pressure to stomach mucous membrane resistance caused by gastric secretion suppressed ability of stress ulcer.
2. Ginkgo Biloba Extract for Cancer, mutation resistance:
As an antioxidant, anti mutation agent and anti-inflammatory agent, resveratrol shows for cancer chemoprevention ability. It also can induce the body early young myelocytic leukemia cell differentiation (value-added) and inhibition of mouse breast cancer tissue lesions before development. Resveratrol also inhibit protein tyrosine kinase a catalytic tyrosine phosphorylation of substances. The kinase involved in regulation of cell mitosis in the cytoplasm of information transmission. The use of resveratrol inhibits protein tyrosine kinases can by preventing kinase plays a role of resistance mutations and function.
3. Ginkgo Biloba Extract for Prevent heart and liver damage:
Resveratrol inhibits the mice liver triglycerides and cholesterol deposition. It also can inhibit fat mice liver peroxidation and prompted aspartic acid transaminase and propyl amine acid transaminase levels rise. Analysis of these two kinds of enzymes in serum to give a good diagnostic information in the heart and liver damage.
4. Ginkgo Biloba Extract for Promote the immune system activity for wound treatment:
Resveratrol also by enhancing the immune system and promote healing of burn. ROM (1993) studied the resveratrol in restoring scald in mice by inhibiting cell sex, humoral and nonspecific immune efficacy. Controlled use of resveratrol provides the immunoregulatory effects of a drug depend on the type. ROM (1995) with different degree such as severe scald in mice studies have shown that resveratrol can restore its ability to function as a response to antigen signal damaged, and proliferation, interleukins. synthesis and by lymphocyte antibody synthesis ability. Severe burns after using controlled resveratrol treatment of animals its level of neutrophil and neutrophil adhesion rate return to near normal levels, and prolong survival time.
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}